Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Anna Reischer"'
Autor:
Elham Khatamzas, Markus H. Antwerpen, Alexandra Rehn, Alexander Graf, Johannes Christian Hellmuth, Alexandra Hollaus, Anne-Wiebe Mohr, Erik Gaitzsch, Tobias Weiglein, Enrico Georgi, Clemens Scherer, Stephanie-Susanne Stecher, Stefanie Gruetzner, Helmut Blum, Stefan Krebs, Anna Reischer, Alexandra Leutbecher, Marion Subklewe, Andrea Dick, Sabine Zange, Philipp Girl, Katharina Müller, Oliver Weigert, Karl-Peter Hopfner, Hans-Joachim Stemmler, Michael von Bergwelt-Baildon, Oliver T. Keppler, Roman Wölfel, Maximilian Muenchhoff, Andreas Moosmann
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-12 (2022)
SARS-CoV-2 mutations associated with the escape from antibody-mediated neutralization have been widely reported. Here, in a patient with defective antibody responses, the authors find a potential association between SARS-CoV-2 mutations and CD8 T alt
Externí odkaz:
https://doaj.org/article/938422b96025423598b966f651261064
Autor:
Siret Tahk, Binje Vick, Björn Hiller, Saskia Schmitt, Anetta Marcinek, Enrico D. Perini, Alexandra Leutbecher, Christian Augsberger, Anna Reischer, Benjamin Tast, Andreas Humpe, Irmela Jeremias, Marion Subklewe, Nadja C. Fenn, Karl-Peter Hopfner
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-17 (2021)
Abstract Background Acute myeloid leukaemia (AML) stem cells (LSCs) cause disease relapse. The CD47 “don’t eat me signal” is upregulated on LSCs and contributes to immune evasion by inhibiting phagocytosis through interacting with myeloid-speci
Externí odkaz:
https://doaj.org/article/283f6b159bc043879ea7f65025d1d5d9
Autor:
Elena Winheim, Linus Rinke, Konstantin Lutz, Anna Reischer, Alexandra Leutbecher, Lina Wolfram, Lisa Rausch, Jan Kranich, Paul R Wratil, Johanna E Huber, Dirk Baumjohann, Simon Rothenfusser, Benjamin Schubert, Anne Hilgendorff, Johannes C Hellmuth, Clemens Scherer, Maximilian Muenchhoff, Michael von Bergwelt-Baildon, Konstantin Stark, Tobias Straub, Thomas Brocker, Oliver T Keppler, Marion Subklewe, Anne B Krug
Publikováno v:
PLoS Pathogens, Vol 17, Iss 10, p e1009742 (2021)
Disease manifestations in COVID-19 range from mild to severe illness associated with a dysregulated innate immune response. Alterations in function and regeneration of dendritic cells (DCs) and monocytes may contribute to immunopathology and influenc
Externí odkaz:
https://doaj.org/article/852e03dd622546c7b68aaac8583d6fbd
Autor:
Erik Gaitzsch, Verena Passerini, Elham Khatamzas, Carolin D. Strobl, Maximilian Muenchhoff, Clemens Scherer, Andreas Osterman, Michael Heide, Anna Reischer, Marion Subklewe, Alexandra Leutbecher, Benjamin Tast, Adrian Ruhle, Tobias Weiglein, Stephanie-Susanne Stecher, Hans J. Stemmler, Martin Dreyling, Philipp Girl, Enrico Georgi, Roman Wölfel, Laura Mateyka, Elvira D’Ippolito, Kilian Schober, Dirk H. Busch, Juliane Kager, Christoph D. Spinner, Matthias Treiber, Sebastian Rasch, Tobias Lahmer, Roman Iakoubov, Jochen Schneider, Ulrike Protzer, Christof Winter, Jürgen Ruland, Michael Quante, Oliver T. Keppler, Michael von Bergwelt-Baildon, Johannes Hellmuth, Oliver Weigert
Publikováno v:
HemaSphere, Vol 5, Iss 7, p e603 (2021)
The clinical and immunological impact of B-cell depletion in the context of coronavirus disease 2019 (COVID-19) is unclear. We conducted a prospectively planned analysis of COVID-19 in patients who received B-cell depleting anti-CD20 antibodies and c
Externí odkaz:
https://doaj.org/article/094ad305bd0d4e23983309dd91f61e83
Autor:
Susann Badmann, Sabine Heublein, Doris Mayr, Anna Reischer, Yue Liao, Thomas Kolben, Susanne Beyer, Anna Hester, Christine Zeder-Goess, Alexander Burges, Sven Mahner, Udo Jeschke, Fabian Trillsch, Bastian Czogalla
Publikováno v:
Cells, Vol 9, Iss 5, p 1224 (2020)
Multi drug resistance protein 1 (MDR1) expression on tumor cells has been widely investigated in context of drug resistance. However, the role of MDR1 on the immune cell infiltrate of solid tumors remains unknown. The aim of this study was to analyze
Externí odkaz:
https://doaj.org/article/1faef99a4309448b9fbe469943d3324c
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 146:1108-1118
Therapy with checkpoint inhibitors still revolutionizes the therapeutical landscape in oncology. Since the first approval of a checkpoint inhibitor for the therapy of malignant melanoma 2011, many other approvals in the field of hematology and oncolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7c682cbe17f462ba0c6c921e425f806
https://doi.org/10.1055/a-1303-8820
https://doi.org/10.1055/a-1303-8820
Autor:
Niklas Thon, Madeleine Flach, Andreas Straube, Thomas Kirchner, Christoph B. Westphalen, Volker Heinemann, Louisa von Baumgarten, Andreas Jung, Jörg Kumbrink, Maximilian Niyazi, Sibylle Liebmann, Julian Walter Holch, Klaus H. Metzeler, Michael von Bergwelt-Baildon, Anna Reischer
Publikováno v:
Theranostics
Background: In the era of precision medicine, cancer treatment is increasingly tailored according to tumor-specific genomic alterations. The analysis of tumor-derived circulating nucleic acids in cerebrospinal fluid (CSF) by next generation sequencin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58c021eb0f7f6cce1dfe867681eb58aa
http://europepmc.org/articles/PMC6929982
http://europepmc.org/articles/PMC6929982
Autor:
Alexandra Rehn, Stephanie Gruetzner, Alexander Graf, Hans-Joachim Stemmler, Stephanie-Susanne Stecher, Helmut Blum, Marion Subklewe, Andreas Moosmann, Maximilian Muenchhoff, Alexandra Hollaus, Oliver T. Keppler, Sabine Zange, Anne-Wiebe Mohr, Alexandra Leutbecher, Johannes C. Hellmuth, Markus Antwerpen, Enrico Georgi, Tobias Weiglein, Michael von Bergwelt-Baildon, Stefan Krebs, Philipp Girl, Anna Reischer, Karl-Peter Hopfner, Oliver Weigert, Elham Khatamzas, Katharina Mueller, Andrea Dick, Clemens Scherer, Erik Gaitzsch, Roman Wölfel
Since its recent zoonotic spill-over severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is constantly adapting to the human host as illustrated by the emergence of variants of concern with increased transmissibility and immune evasion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a77d340e8b847050a08b7f51637ad54b
https://doi.org/10.21203/rs.3.rs-846197/v1
https://doi.org/10.21203/rs.3.rs-846197/v1
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 146(17)
Therapy with checkpoint inhibitors still revolutionizes the therapeutical landscape in oncology. Since the first approval of a checkpoint inhibitor for the therapy of malignant melanoma 2011, many other approvals in the field of hematology and oncolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::949a4232a489e96e6a0957629fce817b
https://pubmed.ncbi.nlm.nih.gov/34448187
https://pubmed.ncbi.nlm.nih.gov/34448187
Autor:
Paul R. Wratil, Linus Rinke, Lina Wolfram, Lisa Rausch, Tobias Straub, Johanna Huber, Clemens Scherer, Maximilian Muenchhoff, Dirk Baumjohann, Anne Krug, Simon Rothenfusser, Oliver T. Keppler, Anna Reischer, Michael von Bergwelt-Baildon, Jan Kranich, Johannes C. Hellmuth, Elena Winheim, Thomas Brocker, Marion Subklewe, Alexandra Leutbecher, Anne Hilgendorff, Konstantin Lutz, Benjamin Schubert, Konstantin Stark
Publikováno v:
PLoS Pathog. 17:e1009742 (2021)
PLoS Pathogens, Vol 17, Iss 10, p e1009742 (2021)
PLoS Pathogens
PLoS Pathogens, Vol 17, Iss 10, p e1009742 (2021)
PLoS Pathogens
Disease manifestations in COVID-19 range from mild to severe illness associated with a dysregulated innate immune response. Alterations in function and regeneration of dendritic cells (DCs) and monocytes may contribute to immunopathology and influenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea9db6a8f24e27569e47feca86b1fc2
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=63298
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=63298